Recurrent integration of human papillomaviruses 16, 45, and 67 near translocation breakpoints in new cervical cancer cell lines

Cancer Research

Volumn 59, Issue 21, 1999, Pages 5615-5624

  Koopman, Louise A ^a   Szuhai, Károly ^a   Van Eendenburg, Jaap D H ^a   Bezrookove, Vladimir ^a   Kenter, Gemma G ^a   Schuuring, Ed ^a   Tanke, Hans ^a   Fleuren, Gert Jan ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CANCER INVASION; CHROMOSOMAL LOCALIZATION; CHROMOSOME MAP; CHROMOSOME REARRANGEMENT; CHROMOSOME TRANSLOCATION; CONTROLLED STUDY; GENE FREQUENCY; HUMAN; HUMAN CELL; INFECTION RISK; PRIORITY JOURNAL; RECURRENT INFECTION; SQUAMOUS CELL CARCINOMA; UTERINE CERVIX CANCER; VERRUCA VULGARIS;

ADULT; AGED; BLOTTING, SOUTHERN; CELL CULTURE TECHNIQUES; DNA, VIRAL; FEMALE; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; INTERPHASE; KARYOTYPING; MIDDLE AGED; PAPILLOMAVIRIDAE; TRANSLOCATION, GENETIC; TUMOR CELLS, CULTURED; UTERINE CERVICAL NEOPLASMS; VIRUS INTEGRATION;

EID: 0033230507     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (55)

1. Zur Hausen, H. Molecular pathogenesis of cancer of the cervix and its causation by specific human papillomavirus types. Curr. Top. Microbiol. Immunol., 186: 131-156, 1994.
2. Bosch, F. X., Manos, M. M., Munoz, N., Sherman, M., Jansen, A. M., Peto, J., Schiffman, M. H., Moreno, V., Kurman, R., and Shah, K. V. Prevalence of human papillomavirus in cervical cancer: a worldwide perspective. International biological study on cervical cancer (IBSCC) Study Group. J. Natl. Cancer Inst., 87: 796-802, 1995.
3. Krul, E. J. T., Van de Vijver, M. J. Schuuring, E., Van Kanten, R. W., Peters, L. A. W., and Fleuren, G. J. Human papillomavirus in malignant cervical lesions in Surinam, a high-risk country, compared to The Netherlands, a low-risk country. Int. J. Gyn. Cancer, in press, 1999.
4. Knebel Doeberitz, M. v., Rittmuller, C., Aengeneyndt, F., Jansen-Durr, P., and Spitkovsky, D. Reversible repression of papillomavirus oncogene expression in cervical carcinoma cells: consequences for the phenotype and E6-p53 and E7-pRB interactions. J. Virol., 68: 2811-2821, 1994.
5. Münger, K., Scheffner, M., Huibregtse, J. M., and Howley, P. M. Interactions of HPV E6, and E7 oncoproteins with tumour suppressor gene products. Cancer Surv., 12: 197-217, 1992.
6. Galloway, D. A., and McDougall, J. K. Human papillomaviruses and carcinomas. Adv. Virus Res., 37: 125-171, 1989.
7. Münger, K., Phelps, W. C., Bubb, V., Howley, P. M., and Schlegel, R. The E6 and E7 genes of the human papillomavirus type 16 together are necessary and sufficient for transformation of primary human keratinocyles. J. Virol., 63: 4417-4421, 1989
8. Pecoraro, G., Lee, M., Morgan, D., and Defendi, V. Evolution of in vitro transformation and tumorigenesis of HPV16 and HPV18 immortalized primary cervical epithelial cells. Am. J. Pathol., 138: 1-8, 1991.
9. Dürst, M., Callahan, D., Jay, G., and Rhim, J. S. Glucocorticoid-enhanced neoplastic transformation of human keratinocytes by human papillomavirus type 16 and an activated ras oncogene. Virology, 173: 767-771, 1989.
10. Atkin, N. B. Cytogenetics of carcinoma of the cervix uteri: a review. Cancer Genet. Cytogenet., 93: 33-39, 1997.
11. Kersemaekers, A. M., Kenter, G. G., Hermans, J., Fleuren, G. J., and van de Vijver, M. J. Allelic loss and prognosis in carcinoma of the uterine cervix. Int. J. Cancer, 79: 411-417, 1998.
12. Larson, A. A., Liao, S. Y., Stanbridge, E. J., Cavenee, W. K., and Hampton, G. M. Genetic alterations accumulate during cervical tumorigenesis and indicate a common origin for multifocal lesions. Cancer Res., 57: 4171-4176, 1997.
13. Park, J. S., Hwang, E. S., Park, S. N., Ahn, H. K., Um, S. J., Kim, C. J., Kim, S. J., and Namkoong, S. E. Physical status and expression of HPV genes in cervical cancers. Gynecol. Oncol., 65: 121-129, 1997.
14. Matsukura, T., Koi, S., and Sugase, M. Both episomal and integrated forms of human papillomavirus type 16 are involved in invasive cervical cancers. Virology, 172: 63-72, 1989.
15. Jeon, S., and Lambert, P. F. Integration of human papillomavirus type 16 DNA into the human genome leads to increased stability of E6 and E7 mRNAs: implications for cervical carcinogenesis. Proc. Natl. Acad. Sci. USA, 92: 1654-1658, 1995.
16. Popescu, N. C., Zimonjic, D., and DiPaolo, J. A. Viral integration, fragile sites, and proto-oncogenes in human neoplasia. Hum. Genet., 84: 383-386, 1990.
17. Sastre-Garau, X., Couturier, J., Favre, M., and Orth, G. A recurrent human papillomavirus integration site at chromosome region 12q14-q15 in SW756 and SK-v cell lines derived from genital tumors. C. R. Acad. Sci. III, 318: 475-478, 1995.
18. Macville, M., Schröck, E., Padilla-Nash, H., Keck, C., Ghadimi, M., Zimonjic, D., Popescu, N. C., and Ried, T. Comprehensive and definitive molecular cytogenetic characterization of HeLa cells by spectral karyotyping. Cancer Res., 59: 141-150, 1999.
19. Dürst, M., Croce, C. M., Gissmann, L., Schwarz, E., and Huebner, K. Papillomavirus sequences integrate near cellular oncogenes in some cervical carcinomas. Proc. Natl. Acad. Sci. USA, 84: 1070-1074, 1987.
20. Couturier, J., Sastre Garau, X., Schneider Maunoury, S., Labib, A., and Orth, G. Integration of papillomavirus DNA near myc genes in genital carcinomas and its consequences for proto-oncogene expression. J. Virol., 63: 4534-4538, 1991.
21. Popescu, N. C., and DiPaolo, J. A. Integration of human papillomavirus 16 DNA and genomic rearrangements in immortalized human keratinocyte lines. Cancer Res., 50: 1316-1323, 1990.
22. Gilles, C., Piette, J., Ploton, D., Doco-Fenzy, M., and Foidart, J. M. Viral integration sites in human papilloma virus-33-immortalized cervical keratinocyte cell lines. Cancer Genet. Cytogenet., 90: 63-69, 1996.
23. Smith, P. P., Friedman, C. L., Bryant, E. M., and McDougall, J. K. Viral integration and fragile sites in human papillomavirus-immortalized human keratinocyle cell lines. Genes Chromosomes Cancer, 5: 150-157, 1992.
24. Tanke, H. J., Wiegant, J., van Gijlswijk, R. P., Bezrookove, V., Pattenier, H., Heetebrij, R. J., Talman, E. G., Raap, A. K., and Vrolijk, J. New strategy for multi-colour fluorescence in situ hybridisation; COBRA: COmbined Binary RAtio labelling. Eur. J. Hum. Genet., 7: 2-11, 1999.
25. Kurman, R. J., Norris, H. J., and Wilkinson, E. Tumors of the cervix. In: J. Rosai and L. H. Sobin (eds.), Atlas of Tumor Pathology: Tumors of the Cervix, Vagina, and Vulva, pp. 37-106. Armed Forces Institute of Pathology. 1992.
26. Hilders, C. G. J. M., Ras, L., Van Eendenburg, J. D. H., Nooyen, Y., and Fleuren, G. J. Isolation and characterization of tumor-infiltrating lymphocytes from cervical carcinoma. Int. J. Cancer, 57: 805-813, 1994.
27. Kersemaekers, A. M., Hermans, J., Fleuren, G. J., and van de Vijver, M. J. Loss of heterozygosity for defined regions on chromosomes 3, 11 and 17 in carcinomas of the uterine cervix. Br. J. Cancer, 77: 192-200, 1998.
28. Greer, C. E., Peterson, S. L., Kiviat, N. B., and Manos, M. M. PCR amplification from paraffin-embedded tissues. Am. J. Clin. Pathol., 95: 117-124, 1991.
29. Tieben, L. M., Ter Schegget, J., Minnaar, R. P., Bouwes Bavinck, J. N., Berkhout, R. J., and Vermeer, B. J. Detection of cutaneous and genital HPV types in clinical samples by PCR using consensus primers. J. Virol. Methods, 42: 265-279, 1993.
30. de Roda Husman, A. M., Walboomers, J. M., van den Brule, A. J., Meijer, C. J., and Snijders, P. J. The use of general primers GP5 and GP6 elongated at their 3′ ends with adjacent highly conserved sequences improves human papillomavirus detection by PCR. J. Gen. Virol., 76: 1057-1062, 1995.
31. Jacobs, M. V., Snijders, P. J. F., van den Brule, A. J. C., Heimerhorst, T. J. M., Meijer, C. J. L. M., and Walboomers, J. M. M. A general primer GP5+/GP6+ mediated PCR-enzyme immunoassay method for the rapid detection of 14 high-risk and 6 low-risk human Papillomavirus genotypes in cervical scrapings. J. Clin. Microbiol., 35: 791-795, 1997.
32. Telenius, H., Carter, N. P., Bebb, C. E., Nordenskjold, M., Ponder, B. A., and Tunnacliffe, A. Degenerate oligonucleotide-primed PCR: general amplification of target DNA by a single degenerate primer. Genomics, 13: 718-725, 1992.
33. Wiegant, J., Ried, T., Nedertof, P. M., van der Ploeg, M., Tanke, H. J., and Raap, A. K. In situ hybridization with fluoresceinated DNA. Nucleic Acids Res., 19: 3237-3241, 1991.
34. Nederlof, P. M., van der Flier, S., Vrolijk, J., Tanke, H. J., and Raap, A. K. Fluorescence ratio measurements of double-labeled probes for multiple in situ hybridization by digital imaging microscopy. Cytometry, 13: 839-845, 1992.
35. Hedley, D. W., Friedlander, M. L., Taylor, I. W., Rugg, C. A., and Musgrove, E. A. Method for analysis of cellular DNA content of paraffin-embedded pathological material using flow cytometry. J. Histochem. Cytochem., 31: 1333-1335, 1983.
36. Vindeløv, L., Christensen, I. J., and Nissen, N. I. A detergent-trypsin method for the preparation of nuclei for flow cytometric DNA analysis. Cytometry, 3: 323-327, 1983.
37. Hiddemann, W., Schumann, J., and Andreef, M. Convention on nomenclature for DNA cytometry. Cytometry, 5: 445-446, 1984.
38. Mincheva, A., Gissmann, L., and Zur Hausen, H. Chromosomal integration sites of human papillomavirus DNA in three cervical cancer cell lines mapped by in situ hybridization. Med. Microbiol. Immunol., 176: 245-256, 1987.
39. Cannizzaro, L. A., Dürst, M., Mendez, M. J., Hecht, B. K., and Hecht, F. Regional chromosome localization of human papillomavirus integration sites near fragile sites, oncogenes, and cancer chromosome breakpoints. Cancer Genet. Cytogenet., 33: 93-98, 1988.
40. Reuter, S., Bartelmann, M., Vogt, M., Geisen, C., Napierski, I., Kahn, T., Delius, H., Lichter, P., Weitz, S., Korn, B., and Schwarz, E. APM-1, a novel human gene, identified by aberrant co-transcription with papillomavirus oncogenes in a cervical carcinoma cell line, encodes a BTB/POZ-zinc finger protein with growth inhibitory activity. EMBO J., 17: 215-222, 1998.
41. Ku, J. L., Kim, W. H., Park, H. S., Kang, S. B., and Park, J. G. Establishment and characterization of 12 uterine cervical-carcinoma cell lines: common sequence variation in the E7 gene of HPV-16-positive cell lines. Int. J. Cancer, 72: 313-320, 1997.
42. Thein, A. T. A., Han, X., Heyderman, E., Fox, M., Steele, S. J., and Parrington, I. M. Molecular cytogenetic analysis of five newly established cervical cancer cell lines using G banding and fluorescence in situ hybridization. Cancer Genet. Cytogenet., 91: 28-36, 1996.
43. Greenspan, D. L., Connolly, D. C., Wu, R., Lei, R. Y., Vogelstein, J. T. C., Kim, Y. T., Mok, J. E., Muñoz, N., Bosch, F. X., Shah, K., and Cho, K. R. Loss of FHIT expression in cervical carcinoma cell lines and primary tumors. Cancer Res., 57: 4692-4698, 1997.
44. Zimonjic, D. B., Druck, T., Ohta, M., Kastury, K., Croce, C. M., Popescu, N. C., and Huebner, K. Positions of chromosome 3p14.2 fragile sites (FRA3B) within the FHIT gene. Cancer Res., 57: 1166-1170, 1997.
45. Wilke, C. M., Hall, B. K., Hoge, A., Paradee, W., Smith, D. I., and Glover, T. W. FRA3B extends over a broad region and contains a spontaneous HPV16 integration site: direct evidence for the coincidence of viral integration sites and fragile sites. Hum. Mol. Genet., 5: 187-195, 1996.
46. Hall, W. S., Goto Mandeville, R., Shih, H. A., Shank, P. R., and Braun, L. Molecular analysis of episomal human papillomavirus type 16 DNA in a cervical carcinoma cell line. Virus Res., 51: 183-195, 1997.
47. Jeon, S., Allen Hoffmann, B. L., and Lambert, P. F. Integration of human papillomavirus type 16 into the human genome correlates with a selective growth advantage of cells. J. Virol., 69: 2989-2997, 1995.
48. Jones, H. W., Jr., McKusick, V. A., Harper, P. S., and Wuu, K. D. George Otto Gey. (1899-1970). The HeLa cell and a reappraisal of its origin. Obstet. Gynecol., 38: 945-949, 1971.
49. Friedl, F., Kimura, I., Osato, T., and Ito, Y. Studies on a new human cell line (SiHa) derived from carcinoma of uterus. I. Its establishment and morphology. Proc. Soc. Exp. Biol. Med., 135: 543-545, 1970.
50. Pattillo, R. A., Hussa, R. O., Story, M. T., Ruckert, A. C., Shalaby, M. R., and Mattingly, R. F. Tumor antigen and human chorionic gonadotropin in CaSki cells: a new epidermoid cervical cancer cell line. Science (Washington DC), 196: 1456-1458, 1977.
51. Giard, D. J., Aaronson, S. A., Todaro, G. J., Arnstein, P., Kersey, J. H., Dosik, H., and Parks, W. P. In vitro cultivation of human tumors: establishment of cell lines derived from a series of solid tumors. J. Natl. Cancer Inst., 51: 1417-1423, 1973.
52. Rheinwald, J. G., and Beckett, M. A. Tumorigenic keratinocyte lines requiring anchorage and fibroblast support cultures from human squamous cell carcinomas. Cancer Res., 41: 1657-1663, 1981.
53. Symonds, R. P. Screening for cervical cancer: different problems in the developing and the developed world. Eur. J. Cancer Care, 6: 275-279, 1997.
54. Geisbill, J., Osmers, U., and Dürst, M. Detection and characterization of human papillomavirus type 45 DNA in the cervical carcinoma cell line MS751. J. Gen. Virol., 78: 655-658, 1997.
55. Kirii, Y., and Matsukura, T. Nucleotide sequence and phylogenetic classification of human papillomavirus type 67. Virus Genes, 17: 117-121, 1998.